Skip to content

Protagonist Therapeutics PTGX Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Repligen logo
RepligenRGEN
-$5.59M-15.7%
Flutter Entertainment logo
Flutter EntertainmentFLUT
-$27M+28.9%
Veeva Systems logo
Veeva SystemsVEEV
-$2.46M+3.3%
T-Mobile US logo
T-Mobile USTMUS
-$1.22B-35.6%
ACM Research logo
ACM ResearchACMR
-$1.25M-18.9%
Hyatt Hotels logo
Hyatt HotelsH
-$8.75M0.0%

Other financials

Income statement

See full
Revenue$56.4M+99.0%
Operating income-$3.6M+81.1%
Net income$3.8M+132%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$193.7M+38.7%
Total debt$9.8M-13.9%
Total equity$655.5M-4.9%
Total assets$697.5M-6.0%

Cash flow

See full
Operating cash flow-$48.9M-139%
CapEx$215.0K-60.6%
Free cash flow-$49.2M-139%

Valuation

See full
Market cap$7.26B+127%
Enterprise value$7.07B+130%
P/S98×+82.6×

Profitability

See full
Operating margin-192.4%-205pp
Net margin-154.9%-182pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity-17.1%-26.1pp
Debt / equity0.0×
Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Protagonist Therapeutics's short- and long-term operating lease liabilities?
Protagonist Therapeutics (PTGX) reported short- and long-term operating lease liabilities of -$547K in Q1 2026.